Related Experiment Videos
Abstract:
Chronic granulomatous disease is a rare, inherited disease occasionally found in adults. It is characterized by repeated infections of the skin, lymph nodes, and viscera. The underlying cause is a metabolic inability of the leukocyte to destroy certain ingested bacteria and fungi that normally are saprophytes. The diagnois should be suspected in children and adults who present with repeated episodes of infection without an apparent underlying cause. The diagnosis can be established by the nitroblue tetrazolium test. Treatment is nonspecific and directed towards the underlying bacterial or mycotic infection rather than the genetically related deficiency of the leukocyte.
Insights
Chronic granulomatous disease (CGD) is a rare inherited disorder affecting leukocytes, leading to recurrent infections. Early diagnosis via the nitroblue tetrazolium test is crucial for managing this condition.
Area of Science:
- Immunology
- Genetics
- Pediatrics
Background:
- Chronic granulomatous disease (CGD) is a rare inherited immunodeficiency.
- It affects the metabolic function of leukocytes, impairing pathogen destruction.
- CGD can manifest in both children and adults.
Observation:
- Patients present with recurrent, severe infections of the skin, lymph nodes, and internal organs.
- Infections are often caused by bacteria and fungi that are typically harmless (saprophytes).
- The underlying cause is a leukocyte inability to eliminate certain ingested microorganisms.
Findings:
- Diagnosis is suspected in individuals with unexplained recurrent infections.
- The nitroblue tetrazolium (NBT) test is a key diagnostic tool.
- Genetic analysis can confirm the specific leukocyte defect.
Implications:
- Early diagnosis and prompt treatment of infections are vital for patient outcomes.
- Treatment focuses on managing opportunistic infections rather than correcting the genetic defect.
- Understanding CGD pathogenesis aids in developing targeted therapies for inherited immune disorders.